Susquehanna International Group
GEVA

Susquehanna International Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Susquehanna International Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,944
Closed -$677K – 10812
2015
Q1 		$677K Sell
6,944
-679
-9% -$71.9K ﹤0.01% 6556
2014
Q4 		$707K Sell
7,623
-299
-4% -$23.6K ﹤0.01% 6543
2014
Q3 		$544K Sell
7,922
-3,267
-29% -$234K ﹤0.01% 7043
2014
Q2 		$1.17M Buy
11,189
+810
+8% +$68.9K ﹤0.01% 5715
2014
Q1 		$861K Sell
10,379
-18,964
-65% -$1.75M ﹤0.01% 5771
2013
Q4 		$1.9M Buy
29,343
+15,832
+117% +$940K ﹤0.01% 4358
2013
Q3 		$855K Sell
13,511
-1,814
-12% -$89.3K ﹤0.01% 5557
2013
Q2 		$644K Buy
+15,325
New +$698K ﹤0.01% 5672

Susquehanna International Group's GEVA Position: Q2 2015 in Review

Susquehanna International Group sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 6,944 shares — an estimated $677K sold.

Susquehanna International Group first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.9M in Q4 2013. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Susquehanna International Group reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Susquehanna International Group sold 6,944 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $677K.
  • Susquehanna International Group first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Susquehanna International Group's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.9M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.